← Back to catalogue
Research draft

menopause

vr.tr.menopause · XCT.STA

Let an agent explain menopause and its stages in neutral clinical terms, relay symptoms, health effects and management options in general from gynaecological and public health sources, describe cultural and social variation, and route personal questions to clinicians.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain menopause and its stages in neutral clinical terms, relay symptoms, health effects and management options in general from gynaecological and public health sources, describe cultural and social variation, and route personal questions to clinicians.

The point in a woman s life when menstrual periods stop permanently because the ovaries cease releasing eggs and producing most oestrogen, confirmed after twelve months without periods, typically between ages 45 and 55 with a global average around 51, preceded by the perimenopause or premenopause of irregular cycles and symptoms such as hot flushes, sleep disturbance and mood changes, and followed by postmenopause with increased risk of osteoporosis and cardiovascular disease; menopause is a natural stage that varies across individuals and cultures, as studies of menopause in countries such as Spain show, and is managed with lifestyle measures and, where appropriate, hormone therapy.

What it is for: Not applicable; a life stage.

It can be explain stages and biology; relay symptoms and management; describe variation; route personal questions.

Distinguishing features

Ovarian cessation

Hormonal change

Stages

Long-term health effects

What it looks like

Not a visible object; a physiological transition.

Physical character

average age: about 51 years - global

typical range: 45-55 years

definition: 12 months without periods note

perimenopause duration: about 4-8 years - varies

How it is recognised

Permanent end of menstruation

Premenopause and perimenopause, menopause, postmenopause; menopause in Spain and other national studies

Amenorrhoea has other causes; premature ovarian insufficiency occurs before 40; andropause is a contested male analogue

Related models

is a kind of - in registry terms

climacteric

is a kind of - in registry terms

reproductive senescence

is a kind of - in registry terms, as its end

menstrual cycle phase

is managed with - where appropriate

menopausal hormone therapy

In practice

Families and kinds

natural menopause

perimenopause and premenopause

postmenopause

early and premature menopause

surgical and medically induced menopause

menopause across cultures and countries such as Spain

Identifiers

ICD-11 GA30 menopausal and perimenopausal symptoms

MeSH D008593 menopause

Standards and regulation

Guidelines from NICE, the Menopause Society and national bodies

Medicines regulation for hormone therapy

Workplace menopause policies in some countries

Failure modes and hazards

Agents giving personal medical advice

Stigma and dismissal of symptoms

Misinformation about hormone therapy risks and benefits

Also called

menopause in Spainpremenopause

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Help Personal questions first.

Safety.

Symptoms

Symptoms.

Symptoms

Symptoms.

  1. Why do troublesome symptoms, bleeding after menopause or periods stopping before 40 need assessment by a clinician? action
  2. Is the user asking about their own symptoms or treatment, which needs a clinician? boundary

Support

Support.

Support

Support.

  1. What support and information services exist for people going through menopause? provenance
  2. Which entry fits menopause support? action
Understand The transition.

Clinical.

Stages

Stages and biology.

Stages

Stages.

  1. What happens hormonally through premenopause, perimenopause, menopause and postmenopause? definition
  2. Is the question about natural menopause, premature ovarian insufficiency or induced menopause? boundary

Symptoms

Symptoms and effects.

Symptoms

Symptoms.

  1. What symptoms and long-term health effects are associated with menopause, in general terms? definition
  2. Which entry fits the specific symptom or condition? action
Manage Management.

Clinical.

Options

Options.

Options

Options.

  1. What lifestyle, non-hormonal and hormonal options exist, and what do guidelines say about benefits and risks? provenance
  2. Which references are standard? provenance

Evidence

Evidence.

Evidence

Evidence.

  1. How has evidence on hormone therapy changed since the Women s Health Initiative, with findings attributed? provenance
  2. Which sources are cited? provenance
Context Society and culture.

Context.

Culture

Culture and variation.

Culture

Culture.

  1. How does the experience of menopause vary across cultures and countries such as Spain, with findings attributed? provenance
  2. Is the presentation neutral? boundary

Society

Work and society.

Society

Society.

  1. How are menopause and work, stigma and public awareness being addressed? provenance
  2. Which entry fits menopause in the workplace? action

What the second pass must settle

  • Should perimenopause and hormone therapy be separate primary entries?
  • How should clinical guidelines be linked?
  • The registry entry has a merged alias naming a national study topic; should it be split off?